1. Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study. Issue 2 (November 2015) Authors: Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranzano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio Journal: Lung cancer Issue: Volume 90:Issue 2(2015:Nov.) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer. (19th August 2019) Authors: De Matteis, Serena; Canale, Matteo; Verlicchi, Alberto; Bronte, Giuseppe; Delmonte, Angelo; Crinò, Lucio; Martinelli, Giovanni; Ulivi, Paola Other Names: Simeone Pasquale Guest Editor. Journal: Journal of oncology Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy. Issue 8 (3rd August 2021) Authors: Bronte, Giuseppe; Cafaro, Alessandro; Pasini, Luigi; Priano, Ilaria; Andrikou, Kalliopi; Cravero, Paola; Burgio, Marco Angelo; Delmonte, Angelo; Crinò, Lucio Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 8(2021) Page Start: 809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial. Issue 7 (July 2017) Authors: Shaw, Alice T; Kim, Tae Min; Crinò, Lucio; Gridelli, Cesare; Kiura, Katsuyuki; Liu, Geoffrey; Novello, Silvia; Bearz, Alessandra; Gautschi, Oliver; Mok, Tony; Nishio, Makoto; Scagliotti, Giorgio; Spigel, David R; Deudon, Stéphanie; Zheng, Cheng; Pantano, Serafino; Urban, Patrick; Massacesi, Crist... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis. Issue 2 (November 2015) Authors: Chiari, Rita; Metro, Giulio; Iacono, Daniela; Bellezza, Guido; Rebonato, Alberto; Dubini, Alessandra; Sperduti, Isabella; Bennati, Chiara; Paglialunga, Luca; Burgio, Marco Angelo; Baglivo, Sara; Giusti, Raffaele; Minotti, Vincenzo; Delmonte, Angelo; Crinò, Lucio Journal: Lung cancer Issue: Volume 90:Issue 2(2015:Nov.) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology. Issue 1 (December 2015) Authors: Bianconi, Fortunato; Baldelli, Elisa; Luovini, Vienna; Petricoin, Emanuel; Crinò, Lucio; Valigi, Paolo Journal: BMC systems biology Issue: Volume 9:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology. Issue 1 (December 2015) Authors: Bianconi, Fortunato; Baldelli, Elisa; Luovini, Vienna; Petricoin, Emanuel; Crinò, Lucio; Valigi, Paolo Journal: BMC systems biology Issue: Volume 9:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment. Issue 5 (May 2015) Authors: Metro, Giulio; Lunardi, Gianluigi; Floridi, Piero; Pascali, Jennifer P.; Marcomigni, Luca; Chiari, Rita; Ludovini, Vienna; Crinò, Lucio; Gori, Stefania Journal: Journal of thoracic oncology Issue: Volume 10:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment. Issue 5 (May 2015) Authors: Metro, Giulio; Lunardi, Gianluigi; Floridi, Piero; Pascali, Jennifer P.; Marcomigni, Luca; Chiari, Rita; Ludovini, Vienna; Crinò, Lucio; Gori, Stefania Journal: Journal of thoracic oncology Issue: Volume 10:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients. Issue 10 (October 2015) Authors: Marchetti, Antonio; Palma, John F.; Felicioni, Lara; De Pas, Tommaso M.; Chiari, Rita; Del Grammastro, Maela; Filice, Giampaolo; Ludovini, Vienna; Brandes, Alba A.; Chella, Antonio; Malorgio, Francesco; Guglielmi, Flavio; De Tursi, Michele; Santoro, Armando; Crinò, Lucio; Buttitta, Fiamma Journal: Journal of thoracic oncology Issue: Volume 10:Issue 10(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗